Rosetta Genomics Ltd. — Form D

Rosetta Genomics Ltd. of REHOVOT, L3, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-09. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Gerald DogonDirectorRehovot, L3
BRIAN MARKISONDirectorROCKVILLE, MD
Joshua RosensweigDirectorRehovot, L3
David SidranskyDirectorGermantown, MD
Tali Yaron-EldarDirectorTel Aviv, L3
Ranit AharonovExecutive OfficerRehovot, L3
Tomer AssisExecutive OfficerRehovot, L3
Kenneth BerlinExecutive OfficerMonmouth Junction, NJ
Oded BiranExecutive OfficerSouthborough, MA
Kenneth BerlinDirectorMonmouth Junction, NJ
Isaac Shoshani BentwichDirectorRehovot, L3
Joshua Shoshani RosensweigDirectorRehovot, L3
Tzipora Shoshani KupitzExecutive OfficerRehovot, L3
Gerald Shoshani DogonDirectorRehovot, L3
Tami Fishman JutkowitzExecutive OfficerRehovot, L3
Brian A MarkisonDirectorRehovot, L3
David Shoshani SidranskyDirectorRehovot, L3
Tali Shoshani Yaron-EldarDirectorRehovot, L3
Keren GivliExecutive OfficerRehovot, L3
Ayelet ChajutExecutive OfficerRehovot, L3
Racheli Shoshani VizmanExecutive OfficerRehovot, L3
Yoav Shoshani CheloucheDirectorRehovot, L3
Moshe Shoshani ManyDirectorRehovot, L3
Tina Fishman EdmonstonExecutive OfficerRehovot, L3

Other filings by this issuer (5)

FiledFormOfferingSold
2011-11-01D$1.9M$1.5M
2011-03-07D/A$2.7M$2.7M
2011-03-07D/A$2.5M$2.5M
2011-03-03D$2.7M$2.7M
2011-03-03D$2.5M$2.5M

More